PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC)
第一作者机构:[1]Tianjin Med Univ Canc Inst & Hosp, Dept Gastr Surg, Tianjin, Peoples R China[2]Shandong Canc Hosp, Dept Gastrointestinal Surg, Jinan, Peoples R China[4]Shandong Univ, Shandong Prov Hosp, Dept Gastrointestinal Surg, Jinan, Peoples R China[5]Henan Prov Peoples Hosp, Dept Gastrointestinal Surg, Zhengzhou, Peoples R China
推荐引用方式(GB/T 7714):
Ding Xuewei,Wang Xuejun,Li Bin,et al.PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC)[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41:364-364.
APA:
Ding, Xuewei,Wang, Xuejun,Li, Bin,Wang, Longgang,Guo, Honghai...&Liang, Han.(2023).PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).JOURNAL OF CLINICAL ONCOLOGY,41,
MLA:
Ding, Xuewei,et al."PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC)".JOURNAL OF CLINICAL ONCOLOGY 41.(2023):364-364